X, L., H, C., P, L., M, W., D, W., J, L., & W, C. (2026). Biliopancreatic diversion with duodenal switch improve polycystic ovary syndrome with decreased serum ceramides. Frontiers in endocrinology, 17, 1720242. https://doi.org/10.3389/fendo.2026.1720242
Chicago Style (17th ed.) CitationX, Li, Chen H, Li P, Wang M, Wu D, Liu J, and Chen W. "Biliopancreatic Diversion with Duodenal Switch Improve Polycystic Ovary Syndrome with Decreased Serum Ceramides." Frontiers in Endocrinology 17 (2026): 1720242. https://doi.org/10.3389/fendo.2026.1720242.
MLA (9th ed.) CitationX, Li, et al. "Biliopancreatic Diversion with Duodenal Switch Improve Polycystic Ovary Syndrome with Decreased Serum Ceramides." Frontiers in Endocrinology, vol. 17, 2026, p. 1720242, https://doi.org/10.3389/fendo.2026.1720242.